Two-Layered Susceptibility Vessel Sign and High Overestimation Ratio on MRI Are Predictive of Cardioembolic Stroke

References

1. 1.↵
   2. Marder VJ,
   3. Chute DJ,
   4. Starkman S, et al

   . Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006;37:2086–93 doi:10.1161/01.STR.0000230307.03438.94 pmid:16794209

   Abstract/FREE Full Text
2. 2.↵
   2. Boeckh-Behrens T,
   3. Kleine JF,
   4. Zimmer C, et al

   . Thrombus histology suggests cardioembolic cause in cryptogenic stroke. Stroke 2016;47:1864–71 doi:10.1161/STROKEAHA.116.013105 pmid:27197854

   Abstract/FREE Full Text
3. 3.↵
   2. Rovira A,
   3. Orellana P,
   4. Alvarez-Sabín J, et al

   . Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 2004;232:466–73 doi:10.1148/radiol.2322030273 pmid:15215546

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Brinjikji W,
   3. Duffy S,
   4. Burrows A, et al

   . Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review. J Neurointerv Surg 2017;9:529–34 doi:10.1136/neurintsurg-2016-012391 pmid:27166383

   Abstract/FREE Full Text
5. 5.↵
   2. Cho KH,
   3. Kim JS,
   4. Kwon SU, et al

   . Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005;36:2379–83 doi:10.1161/01.STR.0000185932.73486.7a pmid:16224077

   Abstract/FREE Full Text
6. 6.↵
   2. Kang DW,
   3. Jeong HG,
   4. Kim DY, et al

   . Prediction of stroke subtype and recanalization using susceptibility vessel sign on susceptibility-weighted magnetic resonance imaging. Stroke 2017;48:1554–59 doi:10.1161/STROKEAHA.116.016217 pmid:28432264

   Abstract/FREE Full Text
7. 7.↵
   2. Zhang R,
   3. Zhou Y,
   4. Liu C, et al

   . Overestimation of susceptibility vessel sign: a predictive marker of stroke cause. Stroke 2017;48:1993–96 doi:10.1161/STROKEAHA.117.016727 pmid:28536172

   Abstract/FREE Full Text
8. 8.↵
   2. Yamamoto N,
   3. Satomi J,
   4. Tada Y, et al

   . Two-layered susceptibility vessel sign on 3-Tesla T2*-weighted imaging is a predictive biomarker of stroke subtype. Stroke 2015;46:269–71 doi:10.1161/STROKEAHA.114.007227 pmid:25477219

   Abstract/FREE Full Text
9. 9.↵
   2. Bracard S,
   3. Ducrocq X,
   4. Mas JL, et al

   ; THRACE investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 2016;15:1138–47 doi:10.1016/S1474-4422(16)30177-6 pmid:27567239

   CrossRefPubMed
10. 10.↵
    European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457–507 doi:10.1159/000131083 pmid:18477843

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Adams HP Jr.,
    3. Bendixen BH,
    4. Kappelle LJ, et al

    . Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial—TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41 doi:10.1161/01.STR.24.1.35 pmid:7678184

    Abstract/FREE Full Text
12. 12.↵
    2. Goldstein LB,
    3. Jones MR,
    4. Matchar DB, et al

    . Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 2001;32:1091–98 doi:10.1161/01.STR.32.5.1091 pmid:11340215

    Abstract/FREE Full Text
13. 13.↵
    2. Bourcier R,
    3. Derraz I,
    4. Delasalle B, et al

    ; THRACE investigators. Susceptibility vessel sign and cardioembolic etiology in the THRACE trial. Clin Neuroradiol 2018 Jun 12. [Epub ahead of print] doi:10.1007/s00062-018-0699-8

    CrossRef
14. 14.↵
    2. Bourcier R,
    3. Détraz L,
    4. Serfaty JM, et al

    . MRI interscanner agreement of the association between the susceptibility vessel sign and histologic composition of thrombi. J Neuroimaging 2017;27:577–82 doi:10.1111/jon.12464 pmid:28771893

    CrossRefPubMed